| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 8 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 3 | DOXORUBICIN | 8 |
| 4 | MECHLORETHAMINE HYDROCHLORIDE | 8 |
| 5 | PREDNISOLONE | 7 |
| 6 | PREDNISOLONE ORAL | 7 |
| 7 | PREDNISOLONE ORAL SOLUTION | 7 |
| 8 | RITUXIMAB | 6 |
| 9 | ROMIDEPSIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MECHLORETHAMINE HYDROCHLORIDE | 8 | 0.0036 |
| 1 | ROMIDEPSIN | 3 | 0.0018 |
| 2 | BEXAROTENE | 2 | 0.0015 |
| 3 | TREOSULFAN | 1 | 0.0004 |
| 4 | CHLORAMBUCIL | 1 | 0.0003 |
| 5 | ACITRETIN | 1 | 0.0002 |
| 6 | TURMERIC | 1 | 0.0002 |
| 7 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 8 | POTASSIUM CITRATE | 1 | 0.0002 |
| 9 | DACARBAZINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 18 |
| 1 | Corticosteroid [EPC] | 9 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 6 |
| 3 | Retinoid [EPC] | 3 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 2 |
| 6 | Platinum-based Drug [EPC] | 2 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 8 | Aromatase Inhibitor [EPC] | 1 |
| 9 | Azole Antifungal [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 2 | 0.0005 |
| 1 | Alkylating Drug [EPC] | 18 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 6 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 8 | Non-Standardized Food Allergenic Extract [EPC] | 1 | 0.0000 |
| 9 | Retinoid [EPC] | 3 | 0.0000 |